Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
2020 · Cell · 1,081 citations
https://doi.org/10.1016/j.cell.2020.11.020
T
Tanya Golubchik
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
176
Papers
14.9K
Citations
52
h-index
96
i10-index
Tanya Golubchik is an academic researcher from The University of Sydney. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & HIV Research and Treatment & HIV/AIDS Research and Interventions. The author has an h-index of 52, co-authored 150 publications.
ORCID: 0000-0003-2765-9828Papers by this author
worksEfficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
2021 · The Lancet · 649 citations
https://doi.org/10.1016/s0140-6736(21)00628-0
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
2021 · Cell Reports · 446 citations
https://doi.org/10.1016/j.celrep.2021.109292
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study
2021 · The Lancet Public Health · 339 citations
https://doi.org/10.1016/s2468-2667(21)00055-4
Effects of control interventions on Clostridium difficile infection in England: an observational study
2017 · The Lancet Infectious Diseases · 311 citations
https://doi.org/10.1016/s1473-3099(16)30514-x
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
2022 · Nature Medicine · 266 citations
https://doi.org/10.1038/s41591-022-01721-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat